{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T09:57:24Z","timestamp":1782813444621,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11596-022-2644-y","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T08:03:06Z","timestamp":1670227386000},"page":"1231-1239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Circulating Levels of Hypoxia-regulating MicroRNAs in Systemic Lupus Erythematosus Patients with Hemolytic Anemia"],"prefix":"10.1007","volume":"42","author":[{"given":"Amira M.","family":"Gamal-Eldeen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinderella A.","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassem M.","family":"Raafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayez","family":"Althobaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman H.","family":"Bassyouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roba M.","family":"Talaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,3]]},"reference":[{"issue":"5","key":"2644_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/BOR.0000000000000420","volume":"29","author":"X Le","year":"2017","unstructured":"Le X, Yu X, Shen N. Novel insights of microRNAs in the development of systemic lupus erythematosus. Curr Opin Rheumatol, 2017,29(5):450\u2013457","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"2644_CR2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.cell.2016.03.008","volume":"165","author":"R Banchereau","year":"2016","unstructured":"Banchereau R, Hong S, Cantarel B, et al. Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients. Cell, 2016,165(3):551\u2013565","journal-title":"Cell"},{"issue":"1","key":"2644_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/0961203318812679","volume":"28","author":"L Pacheco-Lugo","year":"2019","unstructured":"Pacheco-Lugo L, S\u00e1enz-Garc\u00eda J, Navarro Quiroz E, et al. Plasma cytokines as potential biomarkers of kidney damage in patients with systemic lupus erythematosus. Lupus, 2019,28(1):34\u201343","journal-title":"Lupus"},{"issue":"2","key":"2644_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004,116(2):281\u2013297","journal-title":"Cell"},{"issue":"7006","key":"2644_CR5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V. The functions of animal microRNAs. Nature, 2004,431(7006):350\u2013355","journal-title":"Nature"},{"issue":"2","key":"2644_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.immuni.2007.02.005","volume":"26","author":"KD Taganov","year":"2007","unstructured":"Taganov KD, Boldin MP, Baltimore D. MicroRNAs and immunity: tiny players in a big field. Immunity, 2007,26(2):133\u2013137","journal-title":"Immunity"},{"issue":"5","key":"2644_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nri.2016.40","volume":"16","author":"A Mehta","year":"2016","unstructured":"Mehta A, Baltimore D. MicroRNAs as regulatory elements in immune system logic. Nat Rev Immunol, 2016,16(5):279\u2013294","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2644_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2016.06.020","volume":"45","author":"J Liu","year":"2016","unstructured":"Liu J, Qian C, Cao X. Post-Translational Modification Control of Innate Immunity. Immunity, 2016,45(1):15\u201330","journal-title":"Immunity"},{"key":"2644_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-immunol-020711-075013","volume":"30","author":"RM O\u2019Connell","year":"2012","unstructured":"O\u2019Connell RM, Rao DS, Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol, 2012,30:295\u2013312","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"2644_CR10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrg.2016.134","volume":"17","author":"CP Bracken","year":"2016","unstructured":"Bracken CP, Scott HS, Goodall GJ. A network-biology perspective of microRNA function and dysfunction in cancer. Nat Rev Genet, 2016,17(12):719\u2013732","journal-title":"Nat Rev Genet"},{"issue":"2","key":"2644_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.molcel.2010.09.027","volume":"40","author":"AK Leung","year":"2010","unstructured":"Leung AK, Sharp PA. MicroRNA functions in stress responses. Mol Cell, 2010,40(2):205\u2013215","journal-title":"Mol Cell"},{"issue":"5","key":"2644_CR12","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1158\/1078-0432.CCR-07-1755","volume":"14","author":"C Camps","year":"2008","unstructured":"Camps C, Buffa FM, Colella S, et al. hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res, 2008,14(5):1340\u20131348","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2644_CR13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4161\/cbt.7.2.5297","volume":"7","author":"A Giannakakis","year":"2008","unstructured":"Giannakakis A, Sandaltzopoulos R, Greshock J, et al. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther, 2008,7(2):255\u2013264","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"2644_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1549-8719.2011.00154.x","volume":"19","author":"YC Chan","year":"2012","unstructured":"Chan YC, Banerjee J, Choi SY, et al. miR-210: the master hypoxamir. Microcirculation, 2012,19(3):215\u2013223","journal-title":"Microcirculation"},{"issue":"5","key":"2644_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.molmed.2010.03.004","volume":"16","author":"X Huang","year":"2010","unstructured":"Huang X, Le QT, Giaccia AJ. MiR-210\u2014micromanager of the hypoxia pathway. Trends Mol Med, 2010,16(5):230\u2013237","journal-title":"Trends Mol Med"},{"issue":"7","key":"2644_CR16","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1056\/NEJMra0910283","volume":"364","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med, 2011,364(7):656\u2013665","journal-title":"N Engl J Med"},{"issue":"4","key":"2644_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ni.2846","volume":"15","author":"H Wang","year":"2014","unstructured":"Wang H, Flach H, Onizawa M, et al. Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210. Nat Immunol, 2014,15(4):393\u2013401","journal-title":"Nat Immunol"},{"issue":"5","key":"2644_CR18","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","volume":"146","author":"EV Dang","year":"2011","unstructured":"Dang EV, Barbi J, Yang HY, et al. Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1. Cell, 2011,146(5):772\u2013784","journal-title":"Cell"},{"key":"2644_CR19","unstructured":"Crowther M, Podolak-Dawidziak M. Hemolytic Anemia: General Considerations. McMaster Textbook of Internal Medicine. Krak\u00f3w: Medycyna Praktyczna. 2020"},{"issue":"11","key":"2644_CR20","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1982,25(11):1271\u20131277","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2644_CR21","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992,35(6):630\u2013640","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2644_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10875-007-9104-0","volume":"27","author":"HY Chun","year":"2007","unstructured":"Chun HY, Chung JW, Kim HA, et al. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J Clin Immunol, 2007,27(5):461\u2013466","journal-title":"J Clin Immunol"},{"issue":"10","key":"2644_CR23","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.3899\/jrheum.100293","volume":"37","author":"MY Mok","year":"2010","unstructured":"Mok MY, Wu HJ, Lo Y, et al. The relation of interleukin 17 (IL-17) and IL-23 to Th1\/Th2 cytokines and disease activity in systemic lupus erythematosus. J Rheumatol, 2010,37(10):2046\u20132052","journal-title":"J Rheumatol"},{"issue":"20","key":"2644_CR24","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA, 2013,310(20):2191\u20132194","journal-title":"JAMA"},{"issue":"4","key":"2644_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 2001,25(4):402\u2013408","journal-title":"Methods"},{"issue":"S1","key":"2644_CR26","first-page":"1","volume":"34","author":"YH Wu","year":"2020","unstructured":"Wu YH, Chan YF, Hsieh HL, et al. Upregulation of miR-210-5p in Systemic Lupus Erythematosus Impairs Silent Clearance of Dead Cell Remnants. FASEB J, 2020,34(S1), Supplement: Experimental Biology, Meeting Abstracts, Pages 1\u20131.","journal-title":"FASEB J"},{"issue":"1","key":"2644_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11845-017-1634-8","volume":"187","author":"Q Huang","year":"2018","unstructured":"Huang Q, Chen SS, Li J, et al. miR-210 expression in PBMCs from patients with systemic lupus erythematosus and rheumatoid arthritis. Ir J Med Sci, 2018,187(1):243\u2013249","journal-title":"Ir J Med Sci"},{"issue":"12","key":"2644_CR28","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1177\/0961203307084158","volume":"16","author":"Y Dai","year":"2007","unstructured":"Dai Y, Huang YS, Tang M, et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus, 2007,16(12):939\u2013946","journal-title":"Lupus"},{"issue":"12","key":"2644_CR29","first-page":"3810","volume":"117","author":"DF Higgins","year":"2007","unstructured":"Higgins DF, Kimura K, Bernhardt WM, et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest, 2007,117(12):3810\u20133820","journal-title":"J Clin Invest"},{"issue":"4","key":"2644_CR30","doi-asserted-by":"publisher","first-page":"F1023","DOI":"10.1152\/ajprenal.90209.2008","volume":"295","author":"K Kimura","year":"2008","unstructured":"Kimura K, Iwano M, Higgins DF, et al. Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol, 2008,295(4):F1023\u20131029","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"2644_CR31","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3349\/ymj.2012.53.3.587","volume":"53","author":"C Ma","year":"2012","unstructured":"Ma C, Wei J, Zhan F, et al. Urinary hypoxia-inducible factor-1alpha levels are associated with histologic chronicity changes and renal function in patients with lupus nephritis. Yonsei Med J, 2012,53(3):587\u2013592","journal-title":"Yonsei Med J"},{"issue":"6","key":"2644_CR32","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1159\/000369564","volume":"40","author":"W Deng","year":"2014","unstructured":"Deng W, Ren Y, Feng X, et al. Hypoxia inducible factor-1 alpha promotes mesangial cell proliferation in lupus nephritis. Am J Nephrol, 2014,40(6):507\u2013515","journal-title":"Am J Nephrol"},{"key":"2644_CR33","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.molimm.2021.02.019","volume":"133","author":"B Garchow","year":"2021","unstructured":"Garchow B, Maque Acosta Y, et al. HIF-1\u03b1 and miR-210 differential and lineage-specific expression in systemic lupus erythematosus. Mol Immunol, 2021,133:128\u2013134","journal-title":"Mol Immunol"},{"issue":"3","key":"2644_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.preghy.2016.08.093","volume":"6","author":"J Rig\u00f3","year":"2016","unstructured":"Rig\u00f3 J, Molvarec A, Nagy B, et al. Expression analysis of circulating exosomal hsa-miR-210 in hypertensive disorders of pregnancy: Biomarkers, prediction of preeclampsia. Pregnancy Hypertens, 2016,6(3):183","journal-title":"Pregnancy Hypertens"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-022-2644-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-022-2644-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-022-2644-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T16:11:00Z","timestamp":1672330260000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-022-2644-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2644"],"URL":"https:\/\/doi.org\/10.1007\/s11596-022-2644-y","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"1 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}